Completed
Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma
NCT00174746
- Conditions
- Asthma, Bronchial Diseases, Bronchial Spasm, +7 more
- Locations
-
- Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States